Treatment type

Cell Therapy

Treatments and trials using Cell Therapy. Filter by country, access level, or patient stories.

All countries United States Canada United Kingdom Japan China Australia Switzerland European Union Newest Patient Stories

FDA ApprovedUnited States

First FDA-Approved Implant Treatment for MacTel Eye Disease

Encelto (revakinagene taroretcel-lwey) — encapsulated cell implant for macular telangiectasia type 2

FDA approval on 5 March 2025 for Encelto (revakinagene taroretcel-lwey) implant — an allogeneic encapsulated cell-based gene therapy for intravitreal surgical…

This is for adults living with idiopathic macular telangiectasia type 2 — and the caregivers who help them — who may be candidates for labelled US Encelto…

September 21, 2026

FDA ApprovedUnited States

First FDA-Approved Cell Therapy to Reduce Chronic Graft-Versus-Host Disease

TREGZI (allogeneic regulatory T cell immunotherapy with HSPC and T cells-vldq) — donor cell transplant product to help adults with blood cancers stay free of chronic graft-versus-host disease

FDA approval on 30 June 2026 for TREGZI (allogeneic regulatory T cell immunotherapy with HSPC and T cells-vldq) suspension — a donor-matched cell therapy given…

This is for adults with blood cancers who need a matched-donor stem cell transplant after intensive conditioning and who may be candidates for labelled US…

September 11, 2026